Head and Neck Cancer Drugs Market

Head and Neck Cancer Drugs Market, By Drug Class (Chemotherapy, Immunotherapy, and Targeted Therapy), By Sales Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Stores), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


Head and neck cancer is a medical term used to describe different malignant tumors that develop in or around the nose, throat, sinuses, larynx, and mouth. Most head and neck cancers are squamous cell carcinomas. Head and neck cancer is highly curable if detected early, however, the treatment depends on a number of factors.

Market Dynamics:

Growing burden of head and neck cancer, rise in focus on disease diagnosis, increase in cigarette smoking, alcohol consumption, and high use of tobacco, high demand for safe and effective drugs or treatment, and increasing research and development are major factors expected to augment the growth of the global head and neck cancer drugs market.

For instance, in February 2022, University of Cincinnati researchers launched a new clinical trial to examine if the combination of a localized radiation treatment and immunotherapy can be a better treatment for patients with recurrent head and neck cancer.

Moreover, in February 2021, the U.S. FDA granted breakthrough therapy designation to Tipifarnib developed by Kura Oncology, Inc., for the treatment of patients with head and neck squamous cell carcinoma (HNSCC). This is a potent, selective, and orally administered drug.

Key features of the study:

This report provides in-depth analysis of the global head and neck cancer drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.

It profiles key players in the global head and neck cancer drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.

Key companies covered as a part of this study include Merck & Co., Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Astrazeneca Plc., Fresenius Medical Care AG & CO. KGAA, and F. Hoffmann-la Roche Ltd. (Genentech, Inc.,), among others.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.

The global head and neck cancer drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global head and neck cancer drugs market.

Detailed Segmentation:

Global Head and Neck Cancer Drugs Market, By Drug Class:

Chemotherapy

Immunotherapy

Targeted Therapy

Global Head and Neck Cancer Drugs Market, By Sales Channel:

Hospital Pharmacies

Drug Stores & Retail Pharmacies

Online Stores

Global Head and Neck Cancer Drugs Market, By Geography:

North America

Europe

Asia Pacific

Latin America

Middle East

Africa

Company Profiles:

Merck & Co., Inc.

Eli Lilly and Company

Bristol-Myers Squibb Company

Astrazeneca Plc.

Fresenius Medical Care AG & CO. KGAA

F.Hoffmann-la Roche Ltd. (Genentech, Inc.,)


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug Class
Market Snapshot, By Sales Channel
Market Snapshot, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increasing prevalence of head and neck cancer
Adverse effects of head and neck cancer drugs
Increasing demand for safe and effective drugs
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Head and Neck Cancer Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Head and Neck Cancer Drugs Market, By Drug Class, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Chemotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Immunotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Targeted Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
6. Global Head and Neck Cancer Drugs Market, By Sales Channel, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Drug Stores & Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Online Stores
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
7. Global Head and Neck Cancer Drugs Market, By Geography, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Mn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Mn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Mn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Mn)
Middle East and Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Mn)
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Mn)
8. Competitive Landscape
Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Eli Lilly and Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bristol-Myers Squibb Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Astrazeneca Plc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Fresenius Medical Care AG & CO. KGAA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
F. Hoffmann-la Roche Ltd. (Genentech, Inc.)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
9. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Global Head and Neck Cancer Drugs Market” - forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings